FIRMQUARRYResearch workspace

US_FEDERAL process · buyer country US · award

MCKESSON REG MEDICATION FY27Q1 CR - HR 6500 EXP 12.11.2026 MEDICATION FOR INMATE POPULATION 10/01/2026 - 12/11/2026

Department of Justice

Procedure CONT_AWD_15B30727F00000004_1540_36W79720D0001_3600CPV 325412Biotechnology & Pharmaceuticals
Not reported
Data last updated Oct 22, 2026 · Source: USAspending.gov
Buyer identifier
Not reported
Primary supplier
MCKESSON CORPORATION
Procurement method
Not reported
Tender deadline
Not reported
Contract period
Not reported — Not reported
Native value
Not reported
USD comparison
Not shown — no auditable FX observation
Official source
Open notice ↗

Description

MCKESSON REG MEDICATION FY27Q1 CR - HR 6500 EXP 12.11.2026 MEDICATION FOR INMATE POPULATION 10/01/2026 - 12/11/2026

Suppliers

Official lifecycle

Process timeline

  1. Award announced

    MCKESSON REG MEDICATION FY27Q1 CR - HR 6500 EXP 12.11.2026 MEDICATION FOR INMATE POPULATION 10/01/2026 - 12/11/2026

    US · usaspendingSource ↗
  2. Value increased

    MCKESSON REG MEDICATION FY27Q1 CR - HR 6500 EXP 12.11.2026 MEDICATION FOR INMATE POPULATION 10/01/2026 - 12/11/2026

    US · usaspending$80KSource ↗

Auditable model output

Predictive intelligence

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Append-only source history

Source records

RecordDateStagesFetched